Literature DB >> 1383311

Antiallergic properties of the second-generation H1 antihistamines during the early and late reactions to antigen.

R G Townley1.   

Abstract

Some of the second-generation H1 antihistamines reduce the bronchoconstrictor response after exercise and antigen challenge. For example, terfenadine causes a slight but significant increase in forced expiratory volume after 1 second. At doses of 120 and 240 mg, terfenadine has a protective effect against asthma induced by ultrasonic nebulized distilled water and cold air hyperventilation challenge. Certain other newer antihistamines, such as ketotifen, azelastine, and cetirizine, have additional antiallergy properties. These effects include inhibition of eosinophil, basophil, and neutrophil migration and platelet-activating factor-induced eosinophil accumulation in skin. The ability of cetirizine (and perhaps other antihistamines) to inhibit these responses at usual therapeutic doses may be useful in investigating the late allergic reaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383311     DOI: 10.1016/0091-6749(92)90158-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

Review 1.  Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines.

Authors:  Juga Hansen; Ludger Klimek; Karl Hörmann
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines.

Authors:  Greg W Bensch; Harold S Nelson; Larry C Borish
Journal:  Ann Allergy Asthma Immunol       Date:  2002-05       Impact factor: 6.347

Review 3.  Ebastine in context. Introduction.

Authors:  E Buendia
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects.

Authors:  M J Fischer; J J Paulussen; D A Horbach; E P Roelofsen; J C van Miltenburg; N J de Mol; L H Janssen
Journal:  Inflamm Res       Date:  1995-02       Impact factor: 4.575

Review 5.  Pharmacological Management of Allergic Rhinitis in the Elderly.

Authors:  Andrzej Bozek
Journal:  Drugs Aging       Date:  2017-01       Impact factor: 3.923

6.  Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Authors:  Mustafa Cenk Ecevit; Müge Özcan; İlknur Haberal Can; Emel Çadallı Tatar; Serdar Özer; Erkan Esen; Doğan Atan; Sercan Göde; Çağdaş Elsürer; Aylin Eryılmaz; Berna Uslu Coşkun; Zahide Mine Yazıcı; Mehmet Emre Dinç; Fatih Özdoğan; Kıvanç Günhan; Nagihan Bilal; Arzu Yasemin Korkut; Fikret Kasapoğlu; Bilge Türk; Ela Araz Server; Özlem Önerci Çelebi; Tuğçe Şimşek; Rauf Oğuzhan Kum; Mustafa Kemal Adalı; Erdem Eren; Nesibe Gül Yüksel Aslıer; Tuba Bayındır; Aslı Çakır Çetin; Ayşe Enise Göker; Işıl Adadan Güvenç; Sabri Köseoğlu; Gül Soylu Özler; Ethem Şahin; Aslı Şahin Yılmaz; Ceren Güne; Gökçe Aksoy Yıldırım; Bülent Öca; Mehmet Durmuşoğlu; Yunus Kantekin; Süay Özmen; Gözde Orhan Kubat; Serap Köybaşı Şanal; Emine Elif Altuntaş; Adin Selçuk; Haşmet Yazıcı; Deniz Baklacı; Atılay Yaylacı; Deniz Hancı; Sedat Doğan; Vural Fidan; Kemal Uygur; Nesil Keleş; Cemal Cingi; Bülent Topuz; Salih Çanakçıoğlu; Metin Önerci
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.